The Chickenpox Vaccine Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the chickenpox vaccine has seen substantial growth in recent years. It is projected to increase from $3.57 billion in 2024 to $3.8 billion in 2025, implying a compound annual growth rate (CAGR) of 6.6%.
By 2029, the global market for chickenpox vaccines is anticipated to reach $4.93 billion, growing at a compound annual growth rate (CAGR) of 6.7%.
Download Your Free Sample of the 2025 Chickenpox Vaccine Market Report and Uncover Key Trends Now!The key drivers in the chickenpox vaccine market are:
• Rise in public perception and trust towards vaccines
• Heightened focus on pandemic preparedness
• Increased investment in research and development
• Surge in demand from emerging markets and development of healthcare infrastructure.
The chickenpox vaccine market covered in this report is segmented –
1) By Vaccine: Monovalent Varicella Vaccine, Combination Varicella Vaccine
2) By Application: Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immunization, Chickenpox Vaccination
3) By End-Users: Hospitals, Clinics, Other End-Users
The key trends in the chickenpox vaccine market are:
• Public trust and pandemic preparedness are shaping the future of the market.
• Active research and development alongside emerging market demands influence market trends.
• Vaccine education campaigns and event monitoring as safety measures are emerging trends.
• Vaccine pricing strategies, innovative advancements, and AI usage are significantly influencing the future of the market.
Major companies in the chickenpox vaccine market are:
• Merck & Co.
• Sanofi Pasteur
• Takeda Pharmaceutical Company Limited
• CSL Limited
• Pfizer Inc.
• Seqirus
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech
• Emergent BioSolutions Inc.
• Hualan Biological Engineering Inc.
• Shenzhen Kangtai Biological Products Co., Ltd.
• Chongqing Zhifei Biological Products Co., Ltd.
• Beijing Minhai Biotechnology Co., Ltd.
• Adimmune Corporation
• Biological E. Limited
• Walvax Biotechnology Co., Ltd.
• Zydus Cadila
• Indian Immunologicals Ltd.
• Panacea Biotec Ltd.
• Bio Farma
• PT Kalbe Farma Tbk
• CanSino Biologics
North America was the largest region in the chickenpox vaccine market share in 2024